DHA was discovered as a skin-browning agent in the 1920s, when healthcare providers noticed localized skin darkening in children being treated orally with DHA for glycogen storage disease
Conflicts of Interest Eva Vilarrasa has received fees for consulting and/or as a speader and/or for travel and/or has participated in clinical trials sponsored by Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Gebro, Isdin, Janssen, LEO Pharma, Lilly, Merck Serono, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, and UCB
Delivery takes 2-4 business days to most Canadian addresses
Mounjaro and Zepbound contain tirzepatide, a dual-acting agonist that targets both GLP-1 and GIP receptors
Although this study was not designed to examine a dose-response relationship between the exposure and the outcome, this finding may indicate a dose-dependent effect